Ardent Health’s senior executives pushed back against concerns about softening volumes, promising that margin improvement programs and other strategic initiatives would make up the difference.
“Sharper operational execution is my highest priority,” Dave Caspers, the 30-hospital system’s newly appointed CEO, told analysts Wednesday morning. “We will continue to manage through the healthcare head- and tailwinds, but as an operator I am laser-focused on the performance that we can directly influence—how we staff, how we contract, how we allocate capital, how we standardize and how we hold ourselves accountable.”
The for-profit system this week reaffirmed its 2026 guidance even as its second-quarter earnings per share of 12 cents (net income of $17 million) missed analysts’ consensus estimate, per Zacks Investment Research, of 17 cents per share. The company’s revenue during the quarter was $1.62 billion, above the consensus estimate of $1.59 billion.
Those numbers are both a step back from 2025’s second quarter, when net income per diluted share was 52 cents ($73 million net income) and revenue was $1.55 billion.
Executives attributed the slowdown to volume pressures that hit during the quarter’s first two months but broadly recovered in June. Specifically, surgeries and admissions dipped 5% and 2% year over year, respectively, during the first two months but grew in June, resulting in declines of 2.9% and 1% for the full quarter.
“And although July volumes are still below our original expectations entering this year, like June they are improved from April to May volumes,” Chief Financial Officer Alfred Lumsdaine told analysts.
He added that adjusted admissions had increased 2.5% year over year; that net patient revenue per adjusted admission dropped 3.9%, due to the prior year’s recognition of Medicaid state-directed payments and reduced surgery volumes; and an 8% drop in exchange admissions and corresponding increase in self-pay that fell within the company’s prior earnings guidance.
“Volume declines [among exchange patients] have been less pronounced than expected, and our data indicates that those losing exchange coverage are not all moving to self-pay,” Lumdsdaine said of the curveball that stymied the performance of major peers like HCA Healthcare and Community Health Systems. “Instead, we're seeing some trends that indicate a material portion of impacted individuals are finding other insurance coverage. We're continuing to monitor these dynamics, of course, but overall, we remain confident in the $35 million net impact for the year.”
Ardent also reaffirmed its full-year guidance, noting it’s leaning toward the lower end of the $6.4 billion to $6.7 billion total revenue range due to reduced volumes.
Its adjusted EBITDA range of $485 million to $535 million is also maintained. That projection balances a $25 million hit from the second-quarter’s volumes and reduced volume expectations for the remainder of the year against $15 million to $20 million in better-than-expected labor savings from its margin improvement program and $5 million to $10 million more from recontracting with payers.
Within those improvements, executives said the company’s Project IMPACT (Improve Margins, Performance, Agility and Care Transformation) initiative has been advancing ahead of expectations.
Within the company’s operating expenses, salaries, wages and benefits spending growth was limited to 0.7% over the prior year and contract labor spend was cut by 42%, Caspar said. The performance improvement was because “we streamlined our structure to reduce managerial layers at both corporate and field locations,” Lumsdaine said while specifying that Project IMPACT’s gains have been “almost entirely non-clinical in nature and are intended to improve accountability and speed our execution.”
Caspar noted strategic partnerships with companies such as Epic, Ensemble Health and Hello Care AI to bolster revenue cycle, clinical capabilities and virtual care. He also touted the execution of a new framework to better match demand and capacity, which was tested during the quarter’s volume slump and will help guide future service line investments.
Also helpful to Ardent’s bottom line was “a key payer contract renewal” that went into effect on June 1, for which the company negotiated a more favorable rate. Such renegotiations and improved revenue yield are an opportunity for the company going forward, with Caspar telling analysts that “in many instances, our rates rank below the 50th percentile, and we believe we can drive them higher, given our strong market positions, while improving contract term and yield.”
Ardent Health operates 30 acute care hospitals and more than 280 other care sites, with more than half of those hospitals operated on behalf of major nonprofit health systems or academic medical centers with which the for-profit partners. This past year, the company increased its revenues by 6% to $6.3 billion and grew its adjusted EBITDA to $545 million.
The company’s shares were trading nearly 5% above open as of Wednesday afternoon. Executives noted they intend to pursue share repurchases, based on the company’s current valuation.